Boehringer Ingelheim Introduces ERAV Vaccine

Equine rhinitis A virus affects the airways and is spread via nasal secretions and aerosol inhalation.
Share
Favorite
Close

No account yet? Register

ADVERTISEMENT

Boehringer Ingelheim Vetemedica Inc. (BIVI) has introduced a new vaccine for equine rhinitis A virus (ERAV), a sometimes overlooked causative agent of respiratory diseases affecting horses.

This disease, which affects both upper and lower airways, can be spread by contact through nasal secretions and aerosol inhalation.

"We are excited to offer a safe vaccine option for veterinarians and horse owners," said John Tuttle, DVM, senior associate director of equine professional and technical services. "As a worldwide leader in equine health-care solutions, we also have an obligation to help educate the industry about the prevalence, diagnosis and treatment of this disease

Create a free account with TheHorse.com to view this content.

TheHorse.com is home to thousands of free articles about horse health care. In order to access some of our exclusive free content, you must be signed into TheHorse.com.

Start your free account today!

Already have an account?
and continue reading.

Share

Written by:

Related Articles

Stay on top of the most recent Horse Health news with

FREE weekly newsletters from TheHorse.com

Sponsored Content

Weekly Poll

sponsored by:

Where do you primarily feed your horse?
276 votes · 276 answers

Readers’ Most Popular

Sign In

Don’t have an account? Register for a FREE account here.

Need to update your account?

You need to be logged in to fill out this form

Create a free account with TheHorse.com!